EP3936142

TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.6.2020
  • :
    17.1.2024
  • :
    20832900.3
  • :
    28.6.2040
  • :
    TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE

29.6.2020
17.1.2024
  • :
    Hanmi Pharm. Co., Ltd.
  • :
    214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536, KR
  • :
    KWON, Hyun Joo
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    KIM, Jung Kuk
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    PARK, Eun Jin
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    LEE, Jong Min
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    LEE, Jong Suk
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    JO, Hyo Sang
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    CHOI, In Young
  • :
    Hwaseong-si, Gyeonggi-do 18469, KR
  • :
    20190077776
  • :
    28.6.2019
  • :
    KR
  • :
    20200004386
  • :
    13.1.2020
  • :
    KR
  • :
    20200004379
  • :
    13.1.2020
  • :
    KR
  • :
    20200069219
  • :
    8.6.2020
  • :
    KR
  • :
    KR2020008479
  • :
    29.6.2020
  • :
    A61K 38/17, A61P 1/16, A61K 47/68, A61P 29/00, A61P 35/00